Stock Track | Clover Health Plummets 5.35% Intraday on Mixed Earnings and 2026 Guidance Concerns

Stock Track02-27

Clover Health Corp (CLOV) saw its stock price plummet by 5.35% during intraday trading on Friday.

The decline follows the company's release of mixed quarterly financial results and forward-looking guidance. Clover Health reported a quarterly adjusted loss of 10 cents per share for the period ended September 30, 2025, with revenue growing 47.4% year-over-year to $487.71 million. However, the company posted a substantial quarterly loss of $49.32 million, representing a deterioration from the same quarter last year.

Investors reacted negatively to the company's full-year 2026 revenue guidance of $2.81 billion to $2.92 billion, indicating concerns about continued losses despite revenue growth and uncertainty over the path to profitability.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment